Adaptive Biotech sees a 52% jump in 2019 revenue; shares up 4% after hours

On a preliminary basis, Adaptive Biotechnologies (NASDAQ:ADPT) expects 2019 revenues to be $84M – 85M, up ~52% at the midpoint and slightly above consensus of ~$83M.

Final Q4 and 2019 results will be released in late February.

Shares up 4% after hours.

https://seekingalpha.com/news/3533255-adaptive-biotech-sees-52-jump-in-2019-revenue-shares-up-4-after-hours